124 related articles for article (PubMed ID: 32532597)
1. Role of phosphorylated Smad3 signal components in intraductal papillary mucinous neoplasm of pancreas.
Hori Y; Ikeura T; Yamaguchi T; Yoshida K; Matsuzaki K; Ishida M; Satoi S; Okazaki K
Hepatobiliary Pancreat Dis Int; 2020 Dec; 19(6):581-589. PubMed ID: 32532597
[TBL] [Abstract][Full Text] [Related]
2. Smad3 and its phosphoisoforms are prognostic predictors of hepatocellular carcinoma after curative hepatectomy.
Kim SH; Ahn S; Park CK
Hepatobiliary Pancreat Dis Int; 2012 Feb; 11(1):51-9. PubMed ID: 22251470
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD117, CK17, CK20, MUC4, villin and mismatch repair deficiency in pancreatic intraductal papillary mucinous neoplasm.
Detlefsen S; Jakobsen M; Nielsen MFB; Klöppel G; Mortensen MB
Pathol Res Pract; 2021 Jan; 217():153312. PubMed ID: 33341087
[TBL] [Abstract][Full Text] [Related]
4. Transmembrane mucin MUC13 distinguishes intraductal papillary mucinous neoplasms from non-mucinous cysts and is associated with high-risk lesions.
Stiles ZE; Khan S; Patton KT; Jaggi M; Behrman SW; Chauhan SC
HPB (Oxford); 2019 Jan; 21(1):87-95. PubMed ID: 30115565
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic Smad3 signaling induced by chronic inflammation is an early event in ulcerative colitis-associated carcinogenesis.
Kawamata S; Matsuzaki K; Murata M; Seki T; Matsuoka K; Iwao Y; Hibi T; Okazaki K
Inflamm Bowel Dis; 2011 Mar; 17(3):683-95. PubMed ID: 20602465
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis index CD105 (endoglin)/CD31 (PECAM-1) as a predictive factor for invasion and proliferation in intraductal papillary mucinous neoplasm (IPMN) of the pancreas.
Tachezy M; Reichelt U; Melenberg T; Gebauer F; Izbicki JR; Kaifi JT
Histol Histopathol; 2010 Oct; 25(10):1239-46. PubMed ID: 20712008
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.
Murata M; Matsuzaki K; Yoshida K; Sekimoto G; Tahashi Y; Mori S; Uemura Y; Sakaida N; Fujisawa J; Seki T; Kobayashi K; Yokote K; Koike K; Okazaki K
Hepatology; 2009 Apr; 49(4):1203-17. PubMed ID: 19263472
[TBL] [Abstract][Full Text] [Related]
8. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
[TBL] [Abstract][Full Text] [Related]
9. Cross Validation of the Monoclonal Antibody Das-1 in Identification of High-Risk Mucinous Pancreatic Cystic Lesions.
Das KK; Geng X; Brown JW; Morales-Oyarvide V; Huynh T; Pergolini I; Pitman MB; Ferrone C; Al Efishat M; Haviland D; Thompson E; Wolfgang C; Lennon AM; Allen P; Lillemoe KD; Fields RC; Hawkins WG; Liu J; Castillo CF; Das KM; Mino-Kenudson M
Gastroenterology; 2019 Sep; 157(3):720-730.e2. PubMed ID: 31175863
[TBL] [Abstract][Full Text] [Related]
10. Mucin1 shifts Smad3 signaling from the tumor-suppressive pSmad3C/p21(WAF1) pathway to the oncogenic pSmad3L/c-Myc pathway by activating JNK in human hepatocellular carcinoma cells.
Li Q; Liu G; Yuan H; Wang J; Guo Y; Chen T; Zhai R; Shao D; Ni W; Tai G
Oncotarget; 2015 Feb; 6(6):4253-65. PubMed ID: 25714018
[TBL] [Abstract][Full Text] [Related]
11. Surgical strategy for intraductal papillary mucinous neoplasms of the pancreas.
Hirono S; Yamaue H
Surg Today; 2020 Jan; 50(1):50-55. PubMed ID: 31807871
[TBL] [Abstract][Full Text] [Related]
12. Smad3 phosphoisoform-mediated signaling during sporadic human colorectal carcinogenesis.
Matsuzaki K
Histol Histopathol; 2006 Jun; 21(6):645-62. PubMed ID: 16528675
[TBL] [Abstract][Full Text] [Related]
13. Recurrence patterns after surgical resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas; a multicenter, retrospective study of 1074 IPMN patients by the Japan Pancreas Society.
Hirono S; Shimizu Y; Ohtsuka T; Kin T; Hara K; Kanno A; Koshita S; Hanada K; Kitano M; Inoue H; Itoi T; Ueki T; Shimokawa T; Hijioka S; Yanagisawa A; Nakamura M; Okazaki K; Yamaue H
J Gastroenterol; 2020 Jan; 55(1):86-99. PubMed ID: 31463655
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil-to-lymphocyte Ratio as a Predictor of Malignancy of Intraductal Papillary Mucinous Neoplasms.
Sugimachi K; Mano Y; Matsumoto Y; Nakanoko T; Uehara H; Nakashima Y; Sugiyama M; Ota M; Morita M; Toh Y
Anticancer Res; 2021 Mar; 41(3):1663-1669. PubMed ID: 33788763
[TBL] [Abstract][Full Text] [Related]
15. SLC2A1/GLUT1 expression in mural nodules of intraductal papillary mucinous neoplasm of the pancreas.
Oda Y; Aishima S; Shindo K; Fujino M; Mizuuchi Y; Hattori M; Miyazaki T; Tanaka M; Oda Y
Hum Pathol; 2017 Jul; 65():71-78. PubMed ID: 28412205
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic medullary carcinoma developed on a pancreatic intraductal papillary mucinous neoplasm with loss of MSH2 and MSH6 expression: a case report.
Verocq C; Racu ML; Bafort D; Butorano G; Perez-Casanova Garcia L; Navez J; Witterwulghe M; Sheahan K; Swan N; Closset J; Van Laethem JL; Maris C; D'Haene N
Diagn Pathol; 2021 Dec; 16(1):117. PubMed ID: 34895278
[TBL] [Abstract][Full Text] [Related]
17. Smad3 and Smad3 phosphoisoforms are prognostic markers of gastric carcinoma.
Kim SH; Kim KH; Ahn S; Hyeon J; Park CK
Dig Dis Sci; 2013 Apr; 58(4):989-97. PubMed ID: 23179147
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic study of the MIB-1 labeling index (Ki67) and postoperative prognosis for intraductal papillary mucinous neoplasms and ordinary ductal adenocarcinoma.
Takeshita A; Kimura W; Hirai I; Takasu N; Moriya T; Tezuka K; Watanabe T
Pancreas; 2012 Jan; 41(1):114-20. PubMed ID: 22143341
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic efficacy for predicting intraductal papillary mucinous neoplasms of the pancreas with high grade dysplasia or invasive carcinoma based on the surgery indications in different guidelines].
Li B; Guo SW; Shi XH; Shen S; Zhang GX; Gao SZ; Pan YQ; Xu XF; Jin G
Zhonghua Wai Ke Za Zhi; 2021 May; 59(5):359-365. PubMed ID: 33915626
[No Abstract] [Full Text] [Related]
20. The discrete nature and distinguishing molecular features of pancreatic intraductal tubulopapillary neoplasms and intraductal papillary mucinous neoplasms of the gastric type, pyloric gland variant.
Yamaguchi H; Kuboki Y; Hatori T; Yamamoto M; Shimizu K; Shiratori K; Shibata N; Shimizu M; Furukawa T
J Pathol; 2013 Nov; 231(3):335-41. PubMed ID: 23893889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
